New investors, the statement "57% of today's volume was

New Post Public Reply Private Reply Replies (0) Message Board
sox0407
394
New investors, the statement "57% of today's volume was short sales" wasn’t in the source file. The most recent short interest is < 1% of the OS and the most recent failure-to-deliver (naked short) # is a measly 8820 shares. IMHO interpreting short volume as actual short sales is incorrect. This is what FINRA, the exact same source which the #s are posted from, said.

"Thank you for contacting FINRA’s Office of the Ombudsman. Regarding your question, it would be incorrect to assume that short sales comprise 32% of the total volume on that trading day for IPIX . FINRA publishes the daily short sale volume pursuant to an SEC mandate; however, there are various trading anomalies that result in the reported short sale volume often being exaggerated. Thus, the true total short sales volume may be significantly lower than the volume that is reported. Third parties sometimes ignore this and try to claim the ratio is valid to further their own objectives."

https://investorshangout.com/post/view?id=4804282

MMs mark shares short temporarily to execute trades and they are almost always covered in the same day, therefore the actual short % is much lower than the # suggests. If the short volume indicates actual naked shorting, would the criminals be stupid enough to leave incriminating evidence in the FINRA file?

You can also check out these two posts for some detailed explanations.

https://investorshangout.com/post/view?id=4670279

https://investorshangout.com/post/view?id=4816479

Here are the official short interest and failure-to-deliver data.

Settlement Date: 3/29/2018
Current Short: 1,105,305
Previous Short: 1,107,705
Change: -2,400 (-0.22%)
Average Daily Volume: 328,260
Days to Cover: 3.37

http://otce.finra.org/ESI

0.76% of the outstanding shares were short interest.

“In a “naked” short sale, the seller does not borrow or arrange to borrow the securities in time to make delivery to the buyer within the standard two-day settlement period. As a result, the seller fails to deliver securities to the buyer when delivery is due ( known as a “failure to deliver” or “fail” ).”

https://www.sec.gov/investor/pubs/regsho.htm

According to the SEC, only 8820 shares (0.006% of the OS) were failure-to-deliver as of March 9.

20180309|45782D100|IPIX|8820|INNOVATION PHARMACEU|0.68

https://www.sec.gov/data/foiadocsfailsdatahtm

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Dont-give-up.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Rocket Lab Corp: Explosive Growth and Stock Momentum

Updated Category News Views 285

Rocket Lab's Recent Stock Surge Shares of Rocket Lab Corp (NASDAQ: RKLB) have hit a remarkable all-time high, showcasing the company's increasing prominence in the space launch industry. This unprecedented rise in stock value can be largely attributed to a series of lucrative contracts that have instilled confidence among investors. Positive Developments Fueling Investor...

Continue Reading
Michaels Unveils Innovative In-Store Experiences for Creativity

Updated Category News Views 321

Michaels Expands Offerings with The Knit & Sew Shop and The Party Shop Michaels continues to be a prominent name in North America by introducing exciting new store-in-store experiences known as The Knit & Sew Shop and The Party Shop. This strategic move not only enriches the shopping experience for customers, but also reinforces Michaels' position as the largest specialty...

Continue Reading
Liberty Hill Foundation Expands Leadership for Future Impact

Updated Category News Views 109

Liberty Hill Foundation Expands Leadership Team As Liberty Hill Foundation marks an important milestone, it has made significant changes to its executive leadership to bolster its efforts in supporting grassroots organizations in Los Angeles. This transformation is aimed at ensuring long-term sustainability and societal impact during a crucial time in history. New...

Continue Reading
GSK's RSV and Shingles Vaccine Trial Shows Promising Results

Updated Category News Views 124

GSK plc Shares Encouraging Results on Combined RSV and Shingles Vaccines GSK plc (LSE/NYSE: GSK) has just announced encouraging topline findings from an important phase 3 trial involving adults aged 50 and older. This study assessed the immunogenicity, reactogenicity, and safety of AREXVY, a vaccine for respiratory syncytial virus (RSV), when given together with SHINGRIX,...

Continue Reading
Investors Urged to Act as Hasbro Faces Class Action Lawsuit

Updated Category News Views 141

Investors Should Take Action Regarding Hasbro, Inc. Attention investors! A recent announcement has surfaced indicating a class action lawsuit against Hasbro, Inc. This legal action is initiated by Bronstein, Gewirtz & Grossman, LLC, a well-known law firm in the field of securities fraud. The firm aims to represent those individuals and entities that may have suffered...

Continue Reading